These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

940 related items for PubMed ID: 8137285

  • 21. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors.
    Plowman J, Harrison SD, Dykes DJ, Paull KD, Narayanan VL, Tobol HK, Martin J, Griswold DP.
    Cancer Res; 1989 Apr 15; 49(8):1909-15. PubMed ID: 2702634
    [Abstract] [Full Text] [Related]

  • 22. Antitumor activity of cis-dichlorodiammineplatinum(II).
    Wolpert-DeFilippes MK.
    Cancer Treat Rep; 1979 Apr 15; 63(9-10):1453-8. PubMed ID: 498146
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 24. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ, Moyer JD, Suffness M, Harrison SD, Cysyk R, Hamilton TC, Plowman J.
    Cancer Res; 1994 Feb 01; 54(3):724-9. PubMed ID: 8306334
    [Abstract] [Full Text] [Related]

  • 25. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O, Baba M, Saito A, Yamashita T, Sato W, Abe H, Fukazawa N, Suzuki T, Sato S, Naito M, Tsuruo T.
    Oncol Res; 1997 Feb 01; 9(2):61-9. PubMed ID: 9167187
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Kraus-Berthier L, Guilbaud N, Léonce S, Parker T, Genissel P, Guillonneau C, Goldstein S, Atassi G, Pierré A.
    Cancer Chemother Pharmacol; 2002 Aug 01; 50(2):95-103. PubMed ID: 12172972
    [Abstract] [Full Text] [Related]

  • 27. [Antitumor activity of HO-221, a derivative of benzoylphenylurea against human cancer xenografts in nude mice].
    Fujita F, Fujita M, Inaba H, Sugimoto T, Okuyama Y, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Oct 01; 18(13):2255-61. PubMed ID: 1929446
    [Abstract] [Full Text] [Related]

  • 28. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW.
    Clin Cancer Res; 1995 Aug 01; 1(8):847-57. PubMed ID: 9816054
    [Abstract] [Full Text] [Related]

  • 29. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW.
    Cancer Res; 1994 Jun 15; 54(12):3210-7. PubMed ID: 8205541
    [Abstract] [Full Text] [Related]

  • 30. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV, Wallace RE, Murdock KC, Angier RB, Durr FE, Forbes M.
    Cancer Res; 1982 Feb 15; 42(2):440-4. PubMed ID: 7055799
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
    Igarashi K, Koga K, He Y, Shimogori T, Ekimoto H, Kashiwagi K, Shirahata A.
    Cancer Res; 1995 Jun 15; 55(12):2615-9. PubMed ID: 7780977
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors.
    Furusawa S, Mian AM.
    Cancer Treat Rep; 1987 May 15; 71(5):441-6. PubMed ID: 3567967
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Preclinical screening of chemotherapeutic and endocrine agents using human tumor xenografts--nude mouse system].
    Kubota T, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1991 Jul 15; 18(9):1439-47. PubMed ID: 1854214
    [Abstract] [Full Text] [Related]

  • 35. Phase I study of E7010.
    Yamamoto K, Noda K, Yoshimura A, Fukuoka M, Furuse K, Niitani H.
    Cancer Chemother Pharmacol; 1998 Jul 15; 42(2):127-34. PubMed ID: 9654112
    [Abstract] [Full Text] [Related]

  • 36. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR, Chen SF, Behrens CH, Papp LM, Stafford MM, Sun JH, Behrens DL, Fredericks JR, Polkus ST, Sipple P.
    Cancer Res; 1994 Apr 15; 54(8):2199-206. PubMed ID: 8174127
    [Abstract] [Full Text] [Related]

  • 37. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.
    Wang YM, Hu LX, Liu ZM, You XF, Zhang SH, Qu JR, Li ZR, Li Y, Kong WJ, He HW, Shao RG, Zhang LR, Peng ZG, Boykin DW, Jiang JD.
    Clin Cancer Res; 2008 Oct 01; 14(19):6218-27. PubMed ID: 18829501
    [Abstract] [Full Text] [Related]

  • 38. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Apr 01; 42(4):1462-7. PubMed ID: 7060020
    [Abstract] [Full Text] [Related]

  • 39. Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S.
    MacDonald JR, Muscoplat CC, Dexter DL, Mangold GL, Chen SF, Kelner MJ, McMorris TC, Von Hoff DD.
    Cancer Res; 1997 Jan 15; 57(2):279-83. PubMed ID: 9000568
    [Abstract] [Full Text] [Related]

  • 40. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM, Laster WR, Abbott BJ, Venditti J, Baratta M.
    Cancer Res; 1975 Apr 15; 35(4):939-45. PubMed ID: 1116151
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.